The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Shilenkova V.V.

Kafedra otorinolaringologii Iaroslavskoĭ gosudarstvennoĭ meditsinskoĭ akademii

Gornostalev N.Ia.

Kafedra otorinolaringologii Iaroslavskoĭ gosudarstvennoĭ meditsinskoĭ akademii

Midline granuloma: A case report

Authors:

Shilenkova V.V., Gornostalev N.Ia.

More about the authors

Journal: Russian Rhinology. 2016;24(4): 55‑58

Read: 4229 times


To cite this article:

Shilenkova VV, Gornostalev NIa. Midline granuloma: A case report. Russian Rhinology. 2016;24(4):55‑58. (In Russ.)
https://doi.org/10.17116/rosrino201624455-58

References:

  1. Doronin VA. T-cell lymphomas: therapeutic possibilities for a limited choice. Klinicheskaja onkogematologija. 2013;3(6):127-138. (In Russ.).
  2. Tlholoe MM, Kotu M, Khammissa RA, Bida M, Lemmer J, Feller L. Extranodal Natural Killer/T-cell lymphoma, nasal type: ‘midline lethal granuloma.’ A case report. Head Face Med. 2013;9:4. doi:10.1186/1746-160X-9-4
  3. Kalamkaryan AA Mordovtsev VN, Trofimova LYa. Klinicheskaja dermatologija. Redkie i atipichnye dermatozy. Erevan: Ajastan; 1989. (In Russ.).
  4. Li DM, Lun LD. Mucor irregularis infection and lethal midline granuloma: a case report and review of published literature. Mycopathologia. 2012;174(5-6):429-439. doi:10.1007/s11046-012-9559-2
  5. Bhojaraja MV, Kistampally PK, Udupa K, Thomas J. Subcutaneous Panniculitis-Like T-Cell Lymphoma: A Rare Tumour. J Clin Diagn Res. 2016;10(5):29-30. doi:10.7860/jcdr/2016/18458.7824
  6. Doh K, Tagba E, Thiam I. Sarr A, Woto-Gaye G. NK/T-cell Lymphoma of nasal-type: A rare affection with a poor prognosis. Rev Stomatol Chir Maxillofac Chir Orale. 2016;117(3):167-169. doi:10.1016/j.revsto.2016.02.001
  7. Isobe K, Uno T, Tamaru J, Kawakami H, Ueno N, Wakita H, Okada J, Itami J, Ito H. Extranodal natural killer/T-cell lymphoma, nasal type: the significance of radiotherapeutic parameters. Cancer. 2006;106(3):609-615. doi:10.1002/cncr.21656
  8. Yamaguchi M, Kwong YL, Kim WS, Maeda Y, Hashimoto C, Suh C, Izutsu K, Ishida F, Isobe Y, Sueoka E, Suzumiya J, Kodama T, Kimura H, Hyo R, Nakamura S, Oshimi K, Suzuki R. Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, refractory extranodal naturalkiller (NK)/T- cell lymphoma, nasal type: the NK-Cell Tumor Study Group study. J Clin Oncol. 2011;29(33):4410-4416. doi:10.1200/JCO.2011.35.6287

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.